
benztropine (benz-troe-peen)
Apo-Benztropine, Cogentin
Classification
Therapeutic: antiparkinson agents
Pharmacologic: anticholinergics
Pregnancy Category C
Indications
Adjunctive treatment of all forms of Parkinson’s disease, including drug-induced extrapyramidal effects and acute dystonic reactions.
Action
Blocks cholinergic activity in the CNS, which is partially responsible for the symptoms of Parkinson’s disease.
Restores the natural balance of neurotransmitters in the CNS.
Therapeutic Effects: Reduction of rigidity and tremors.
Pharmacokinetics
Absorption: Well absorbed following PO and IM administration.
Distribution: Unknown.
Metabolism...